JP2003516967A - １，３，４−置換ピペリジン類似体および嗜癖の治療におけるそれらの使用 - Google Patents

１，３，４−置換ピペリジン類似体および嗜癖の治療におけるそれらの使用

Info

Publication number
JP2003516967A
JP2003516967A JP2001544683A JP2001544683A JP2003516967A JP 2003516967 A JP2003516967 A JP 2003516967A JP 2001544683 A JP2001544683 A JP 2001544683A JP 2001544683 A JP2001544683 A JP 2001544683A JP 2003516967 A JP2003516967 A JP 2003516967A
Authority
JP
Japan
Prior art keywords
alkyl
aryl
compound
formulation
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001544683A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003516967A5 (enExample
Inventor
マイルズ ピー． スミス
Original Assignee
バイオストリーム セラピューティクス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオストリーム セラピューティクス filed Critical バイオストリーム セラピューティクス
Publication of JP2003516967A publication Critical patent/JP2003516967A/ja
Publication of JP2003516967A5 publication Critical patent/JP2003516967A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2001544683A 1999-12-16 2000-12-18 １，３，４−置換ピペリジン類似体および嗜癖の治療におけるそれらの使用 Pending JP2003516967A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17113999P 1999-12-16 1999-12-16
US60/171,139 1999-12-16
PCT/US2000/034504 WO2001044193A1 (en) 1999-12-16 2000-12-18 1,3,4-substituted piperidine analogs and uses thereof in treating addictions

Publications (2)

Publication Number Publication Date
JP2003516967A true JP2003516967A (ja) 2003-05-20
JP2003516967A5 JP2003516967A5 (enExample) 2008-02-21

Family

ID=22622694

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001544683A Pending JP2003516967A (ja) 1999-12-16 2000-12-18 １，３，４−置換ピペリジン類似体および嗜癖の治療におけるそれらの使用

Country Status (5)

Country Link
US (1) US20020025967A1 (enExample)
EP (1) EP1248770A1 (enExample)
JP (1) JP2003516967A (enExample)
CA (1) CA2395075A1 (enExample)
WO (1) WO2001044193A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
NZ544331A (en) 2003-07-22 2010-03-26 Arena Pharm Inc Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
KR20080013853A (ko) * 2005-02-23 2008-02-13 사이케노믹스, 인코퍼레이티드 복수매개물질 도파민 수송체 저해물질 및 이와 관련된 용도
US8258305B2 (en) 2005-02-23 2012-09-04 Prexa Pharmaceuticals, Inc. Dopamine transporter inhibitors for use in treatment of movement disorders and other CNS indications
TWI415845B (zh) 2006-10-03 2013-11-21 Arena Pharm Inc 用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
ES2421237T7 (es) 2007-08-15 2013-09-30 Arena Pharmaceuticals, Inc. Derivados de imidazo[1,2-a]piridin como moduladores del receptor serotoninérgico 5ht2a en el tratamiento de trastornos relacionados con el mismo
WO2009123714A2 (en) 2008-04-02 2009-10-08 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
TR201805216T4 (en) 2008-10-28 2018-06-21 Arena Pharm Inc COMPOSITIONS OF A USEFUL 5-HT2A SEROTONINE RECEPTOR MODULATOR FOR THE TREATMENT OF RELATED DISORDERS
US9126946B2 (en) 2008-10-28 2015-09-08 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
CA2877526A1 (en) 2012-06-20 2013-12-27 Novartis Ag Complement pathway modulators and uses thereof
EP3174864A4 (en) 2014-07-31 2018-02-14 Oregon Health & Science University Vmat inhibitory compounds
CA2964103C (en) 2014-10-31 2022-08-30 Indivior Uk Limited Dopamine d3 receptor antagonist compounds
JP2018516992A (ja) 2015-06-12 2018-06-28 アクソファント サイエンシーズ ゲーエムベーハーＡｘｏｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体
CN108472285A (zh) 2015-07-15 2018-08-31 阿速万科学有限责任公司 用于预防和治疗与神经退行性疾病相关联的幻觉的二芳基和芳基杂芳基脲衍生物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1058058B (de) * 1954-02-27 1959-05-27 Basf Ag Verfahren zur Herstellung von Alkylpyridinen
GB850417A (en) * 1957-05-31 1960-10-05 Merck & Co Inc Process for the preparation of 1-(p-nitrophenyl)-4-carboalkoxy-4-phenyl-piperidines
JP2002526528A (ja) * 1998-10-07 2002-08-20 ジョージタウン ユニヴァーシティー 単量体およびニ量体の複素環、ならびにその治療的使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443451A (en) * 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
DE3441927A1 (de) * 1984-11-16 1986-05-28 Basf Ag, 6700 Ludwigshafen Am stickstoff substituierte 4-(p-tert.butyl-phenyl)-3-methyl-piperidine, dessen quartaere salze sowie deren anwendung als fungizide
US5620993A (en) * 1995-06-07 1997-04-15 Merck & Co., Inc. Alpha-1a adrenergic receptor antagonists
ES2329739T3 (es) * 1997-04-07 2009-11-30 Georgetown University Analogos de cocaina.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1058058B (de) * 1954-02-27 1959-05-27 Basf Ag Verfahren zur Herstellung von Alkylpyridinen
GB850417A (en) * 1957-05-31 1960-10-05 Merck & Co Inc Process for the preparation of 1-(p-nitrophenyl)-4-carboalkoxy-4-phenyl-piperidines
JP2002526528A (ja) * 1998-10-07 2002-08-20 ジョージタウン ユニヴァーシティー 単量体およびニ量体の複素環、ならびにその治療的使用

Also Published As

Publication number Publication date
EP1248770A1 (en) 2002-10-16
CA2395075A1 (en) 2001-06-21
WO2001044193A1 (en) 2001-06-21
US20020025967A1 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
JP2514137B2 (ja) キヌクリジン誘導体
RU2139867C1 (ru) Новые 4-арилпиперазины и 4-арилпиперидины, фармацевтическая композиция, способ ингибирования допамин-2-рецепторов
US6472422B2 (en) Analogs of cocaine
JPH05501540A (ja) Ｐｃｐレセプター・リガンドおよびその用途
JP2661699B2 (ja) ピペリジンオピオイド拮抗剤
Dutta et al. Dopamine transporter as target for drug development of cocaine dependence medications
JPH03145488A (ja) 新規ニコチン類似体
US20020025967A1 (en) N-alkylpiperdine analogs and uses thereof in treating addictions
NZ205269A (en) 4-(3-trifludromethylphenyl)-1,2,3,6-tetrahydro-pyridine derivatives and pharmaceutical compositions
US3983239A (en) Hexahydro-γ-carboline derivatives and their salts
Deutsch et al. Synthesis and pharmacology of site specific cocaine abuse treatment agents: a new synthetic methodology for methylphenidate analogs based on the Blaise reaction
US9463187B2 (en) Methylphenidate derivatives and uses of them
EP0861252B1 (fr) Derives naphtamide de 3-beta-amino azabicyclo octane ou nonane, comme agents antipsychotiques
NZ242305A (en) Pyrido-,pyrrolo-,thieno- and dibenzo-diazepine derivatives; preparatory processes and pharmaceutical compositions
EP0389425B1 (de) Neue Benzothiopyranylamine
WO1992006958A1 (en) 4-acetoxy-piperidine derivatives, process for their preparation and use as a muscarinic m3-receptor antagonist
JPH07509711A (ja) 新規なピリジル−およびピリミジルピペラジン誘導体
EP1841752B1 (en) 3,4-dihydro-2-naphthamide derivatives and their therapeutic applications
KR20000029564A (ko) 5ＨＴ2ｃ길항제및Ｄ2길항제를함유하는약제학적조성물
AU597187B2 (en) 2-{ (4-piperidyl)methyl}benzofuro{2,3-c}pyridine derivatives, their preparation and their application in therapy
US3497501A (en) Heterocyclic amino esters of 2-phenylacrylic acid
US4062956A (en) Substituted 2-(2-hydroxyethyl)tetrahydro-1,4 oxazines and quaternary salts thereof useful for treating spasmodic syndromes
JPS61140581A (ja) １，４‐ジヒドロピリジン誘導体
US3959300A (en) Novel indolobenzazepine derivatives, useful as tranquilizers
Casy et al. Further Analgesics Based on Piperidine and Related Azacycloalkanes: Prodines, Promedols, Profadol, and Their Derivatives

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071217

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071217

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090206

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20090713

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20090713

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110602

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20111102